Zacks Investment Research on MSN
Will ResMed (RMD) beat estimates again in its next earnings report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...
ResMed (NYSE:RMD) has agreed to divest its MatrixCare business to a private equity buyer. The deal centers on refocusing the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Zacks Investment Research on MSN
ResMed (RMD) soars 4.2%: Is further upside left in the stock?
ResMed RMD shares rallied 4.2% in the last trading session to close at $218.4. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.
Medical device company ResMed (NYSE:RMD) will be announcing earnings results this Thursday afternoon. Here’s what to look for. ResMed beat analysts’ revenue expectations last quarter, reporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results